Credit Suisse Ag Rigel Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $81,044 - $1.44 Million	-120,962 Reduced 99.99%	7 $0
Q3 2022 Nov 10, 2022	BUY	$1.1 - $12.2 $984 - $10,919	895 Added 0.75%	120,969 $143,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $11,113 - $52,912	-16,587 Reduced 12.14%	120,074 $136,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $19,782 - $30,742	8,911 Added 6.98%	136,661 $409,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $8,890 - $13,448	3,767 Added 3.04%	127,750 $338,000
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $65,425 - $84,118	18,693 Added 17.75%	123,983 $450,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $180,857 - $265,726	-58,530 Reduced 35.73%	105,290 $458,000
Q1 2021 May 14, 2021	SELL	$3.35 - $4.93 $579,081 - $852,199	-172,860 Reduced 51.34%	163,820 $561,000
Q4 2020 Feb 12, 2021	SELL	$2.35 - $3.74 $109,380 - $174,078	-46,545 Reduced 12.15%	336,680 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $394,804 - $916,034	221,800 Added 137.4%	383,225 $919,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $3,391 - $4,930	2,405 Added 1.51%	161,425 $296,000
Q1 2020 May 13, 2020	SELL	$1.27 - $3.0 $202,994 - $479,514	-159,838 Reduced 50.13%	159,020 $247,000
Q4 2019 Feb 12, 2020	BUY	$1.6 - $2.43 $19,584 - $29,743	12,240 Added 3.99%	318,858 $683,000
Q3 2019 Nov 12, 2019	BUY	$1.63 - $2.62 $81,341 - $130,745	49,903 Added 19.44%	306,618 $574,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $166,163 - $214,695	82,259 Added 47.15%	256,715 $669,000
Q1 2019 May 14, 2019	SELL	$2.0 - $2.65 $86,706 - $114,885	-43,353 Reduced 19.9%	174,456 $448,000
Q4 2018 Feb 13, 2019	BUY	$2.08 - $3.36 $120,981 - $195,431	58,164 Added 36.43%	217,809 $501,000
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $1.88 Million - $2.59 Million	-722,040 Reduced 81.89%	159,645 $513,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $2.04 Million - $2.96 Million	719,135 Added 442.41%	881,685 $2.5 Million
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $170,631 - $218,832	-48,201 Reduced 22.87%	162,550 $575,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $396,388 - $527,700	122,721 Added 139.41%	210,751 $817,000
Q3 2017 Nov 14, 2017	SELL	$2.18 - $2.57 $76,191 - $89,821	-34,950 Reduced 28.42%	88,030 $223,000
Q2 2017 Aug 14, 2017	BUY	N/A	122,980	122,980 $335,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account